Literature DB >> 33517503

Anesthetic management for the sleep-awake-sleep technique of awake craniotomy using a novel benzodiazepine remimazolam and its antagonist flumazenil.

Akari Yoshida1, Saori Kurata1, Kotaro Kida1, Tsunehisa Tsubokawa2.   

Abstract

Entities:  

Year:  2021        PMID： 33517503      PMCID： PMC7847922          DOI： 10.1186/s40981-021-00417-z

Source DB:  PubMed          Journal:  JA Clin Rep        ISSN： 2363-9024


× No keyword cloud information.
  3 in total

Review 1.  Adverse Events Associated with Flumazenil Treatment for the Management of Suspected Benzodiazepine Intoxication--A Systematic Review with Meta-Analyses of Randomised Trials.

Authors:  Elisabeth I Penninga; Niels Graudal; Morten Baekbo Ladekarl; Gesche Jürgens
Journal:  Basic Clin Pharmacol Toxicol       Date:  2015-07-28       Impact factor: 4.080

Review 2.  Anaesthesia Management for Awake Craniotomy: Systematic Review and Meta-Analysis.

Authors:  Ana Stevanovic; Rolf Rossaint; Michael Veldeman; Federico Bilotta; Mark Coburn
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240
  3 in total
  4 in total

1.  Remimazolam use for awake craniotomy.

Authors:  Shunsuke Tachibana; Kengo Hayamizu; Michiaki Yamakage
Journal:  JA Clin Rep       Date:  2021-03-15

2.  Remimazolam and low-dose flumazenil for awake craniotomy.

Authors:  Hiroaki Murata; Akihiro Yokoyama; Tetsuya Hara
Journal:  J Anesth       Date:  2022-09-12       Impact factor: 2.931

Review 3.  Profile of Remimazolam in Anesthesiology: A Narrative Review of Clinical Research Progress.

Authors:  Mi Wang; Xian Zhao; Pengfei Yin; Xiuxia Bao; Hongli Tang; Xianhui Kang
Journal:  Drug Des Devel Ther       Date:  2022-10-03       Impact factor: 4.319

4.  The effect of remimazolam on postoperative memory retention and delayed regeneration in breast surgery patients: Rationale and design of an exploratory, randomized, open, propofol-controlled, single-center clinical trial: A study protocol.

Authors:  Kazuhiro Shirozu; Keiko Nobukuni; Kouta Funakoshi; Taizo Nakamura; Makoto Sumie; Midoriko Higashi; Ken Yamaura
Journal:  Medicine (Baltimore)       Date:  2021-12-03       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.